Genetic and biochemical studies led to the identification of a number of genes involved in the etiology of CMDs and revealed that alterations in post-translational processing of dystroglycan underlie MEB/WWS [9]–[15]. This evidence concerns the gene DAG1 and muscle-eye-brain disease.